Trump Recuperates Amid Questions About His Health and Campaign
(Bloomberg) -- Donald Trump's condition remains clouded by confusion over his treatment for Covid-19, with the president's effort to show strength contradicted by conflicting accounts from his doctors that raise doubts about how soon he'll be able return to work and his re-election campaign.
Trump made a surprise outing from Walter Reed National Military Medical Center on Sunday, waving to supporters gathered outside from his motorcade and saying in a video posted on Twitter that he's learned a lot about virus. “I get it,” he said. On Monday morning, he returned to Twitter more energetically, with a slew of all-caps posts urging supporters to vote.
A member of his medical team, Brian Garibaldi, a pulmonary expert at Johns Hopkins University, said at a briefing on Sunday that the president could be released from the hospital as soon as Monday.
But the White House physician, Sean Conley, disclosed for the first time that he was given supplemental oxygen and has received a medication that's typically used in more severe Covid-19 patients. That raises questions about the president's condition as he heads into a phase of the illness where the health of some patients worsens suddenly and dramatically.
The questions about Trump's treatment and recovery as well as demands for more complete disclosure about his health come amid the prospect of widening outbreak among White House and campaign staff and Senate Republicans, even as campaign aides predicted the president would soon be back on the campaign trail.
Earlier: Trump Makes Surprise Outing From Hospital to Greet Supporters
“We have to trust that what they're telling us about the president's condition is real,” House Speaker Nancy Pelosi said on CBS's “Face the Nation,” adding that she's getting details about Trump's health from the press and alleging that Trump is approving the medical team's public statements.
But Conley also revealed that Trump's blood-oxygen saturation level dropped twice since his diagnosis, and that the president's medical team decided to administer dexamethasone, a steroid used to treat inflammation in Covid patients. Asked about X-rays and CT scans of the president's lungs, Conley said there were “some expected findings” but nothing “of any major clinical concern.”
“The president is not out of the woods,” said William Schaffner, an infectious disease doctor at Vanderbilt University. Trump's doctor was “very evasive” in discussing what lung scans had showed, he said. The disease's effects on patients' lungs is often worse than is indicated by their outward symptoms. “It is kind of a stealth infection,” Schaffner added.
Asked why he didn't disclose during Saturday's briefing that Trump had received oxygen despite repeated questions about it, Conley said, “I was trying to reflect the upbeat attitude” of the team and the president.
Trump's Covid Treatment and What the Options Are: QuickTake
“I didn't want to give any information that might steer the course of illness in another direction, and in doing so, it came off that we were trying to hide something, which wasn't necessarily true,” Conley said.
On Monday, Trump didn't immediately provide an update on his condition in a number of campaign tweets, focusing instead on the stock market's climb during his administration and the threat of economic damage from his challenger's policies. He also reiterated his pledge for another tax cut and boasted about what he sees has his administration's accomplishments.
The president first tested positive after he returned from a fundraiser at his New Jersey golf resort on Thursday, White House Press Secretary Kayleigh McEnany told reporters on Sunday evening. Trump made an appearance on Fox News on Thursday night before disclosing on Twitter shortly after midnight on Friday that he had tested positive.
Trump campaign senior aide Jason Miller said on NBC's “Meet the Press” on Sunday that Trump would soon be “ready to get back to the campaign trail,” and in a separate appearance on ABC's “This Week,” Miller downplayed a new NBC-Wall Street Journal poll that showing Joe Biden, the Democratic nominee, leading Trump by 14 percentage points. The campaign is optimistic about Trump's prospects in key battleground states needed to get to 270 electoral votes, he said.
But almost 3.3 million people have already cast ballots for the Nov. 3 election, according to data compiled by University of Florida professor Michael McDonald. David Gergen, a former White House aide to both Democrats and Republicans, said it's unacceptable that the Americans public doesn't know the full extent of Trump's condition.
“The voters should have full information about the outlook for the president's health before they cast a vote,” Gergen said on CNN.
Read More: Trump Tempted Fate Long Before Rose Garden Coronavirus Cluster
Questions have also arisen about whether Trump's White House and campaign events became super spreader locations for the virus. Hope Hicks, a top aide to the president; his campaign manager, Bill Stepien; his debate coach, former New Jersey Governor Chris Christie; and Republican Senators Thom Tillis of North Carolina, Mike Lee of Utah and Ron Johnson of Wisconsin have tested positive for coronavirus infection.
Scott Gottlieb, a former Food and Drug Administration commissioner, said on CBS it's “likely” there will be additional Covid-19 cases stemming from the outbreak in the White House and among Republican lawmakers.
“Anyone who was with the president on Tuesday, Wednesday is not in the clear,” Gottlieb said on “Face the Nation.”
A debate between Vice President Mike Pence and California Senator Kamala Harris, Biden's running mate, is set to take place at the University of Utah on Wednesday. Biden, whose campaign said Sunday night that he again tested negative for Covid-19, is scheduled to travel to Florida on Monday for a campaign event in Miami and an NBC News town hall.
At the same time, Senate Minority Leader Chuck Schumer said it won't be safe for the Senate to move ahead with Supreme Court hearings for Amy Coney Barrett given the virus outbreak that sickened the three Republican senators. Senate Majority Leader Mitch McConnell has said the hearings would go forward as scheduled on Oct. 12 and that senators could attend remotely, though they would have to be present for a vote.
Unfinished Business
Other unfinished business in Washington involves a new stimulus package to bolster an economic recovery and help for beleaguered airlines. Trump tweeted on Saturday that the country “wants & needs stimulus,” and he urged the parties to “work together and get it done.”
Treasury Secretary Steven Mnuchin spoke with the president on Saturday to discuss the administration's efforts to pass another round of stimulus, according to one person familiar with the the matter. The administration still sees the best pitch for more coronavirus relief at about $1.5 trillion, the person said.
House Democrats last Thursday passed a $2.2 trillion package as their latest offer, and Pelosi said on CBS that “we are making progress.” But when asked whether anything could happen this week, she said that will depend on whether Republicans “understand what we have to do to crush the virus.”
©2020 Bloomberg L.P.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.